Intracanalicular Insert
Showing 1 - 25 of 442
Dry Eye Syndromes Trial in Racine (Dextenza 0.4Mg Intracanalicular Insert, Over the counter Artificial tears)
Completed
- Dry Eye Syndromes
- Dextenza 0.4Mg Intracanalicular Insert
- Over the counter Artificial tears
-
Racine, WisconsinThe Eye Center of Racine
Apr 21, 2022
Vitreoretinopathy, Coats' Disease, Exudative Retinopathy Trial in Durham (Dextenza 0.4Mg Ophthalmic Insert, Pred Forte)
Not yet recruiting
- Vitreoretinopathy
- +8 more
- Dextenza 0.4Mg Ophthalmic Insert
- Pred Forte
-
Durham, North CarolinaDuke Eye Center
Nov 10, 2022
Pterygium Trial in New York (Dexamethasone Intracanalicular Insert, 0.4mg, Prednisolone Acetate 1%)
Completed
- Pterygium
- Dexamethasone Intracanalicular Insert, 0.4mg
- Prednisolone Acetate 1%
-
New York, New YorkNew York Eye Specialists
Apr 4, 2022
Cataract Trial in Dayton (Dextenza 0.4Mg Ophthalmic Insert)
Completed
- Cataract
- Dextenza 0.4Mg Ophthalmic Insert
-
Dayton, OhioIworks Laser & Vision Center
Dec 22, 2022
Keratoconus, Unstable, Collagen Crosslinking, Postoperative Pain Trial in Babylon (Dextenza, Prednisolone Acetate)
Active, not recruiting
- Keratoconus, Unstable
- +2 more
- Dextenza
- Prednisolone Acetate
-
Babylon, New YorkSightMD
Jan 18, 2022
Open Angle Glaucoma and Ocular Hypertension Trial in Cincinnati (Ophthalmic Insert)
Completed
- Open Angle Glaucoma and Ocular Hypertension
- Ophthalmic Insert
-
Cincinnati, OhioApexEye
Aug 10, 2021
Pharmacokinetics, Aqueous Dexamethasone, Inflammatory Cytokine Response Trial in Wilkes-Barre (Dexamethasone Ophthalmic implant)
Enrolling by invitation
- Pharmacokinetics
- +2 more
- Dexamethasone Ophthalmic implant
-
Wilkes-Barre, PennsylvaniaBucci Laser Vision
Sep 27, 2021
Graft Vs Host Disease Trial in Boston (DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use, Regular
Withdrawn
- Graft Vs Host Disease
- DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use
- Regular dissolvable intracanalicular plug
-
Boston, MassachusettsMass Eye and Ear
Dec 14, 2021
Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain Trial in Cleveland (Dexamethasone Ophthalmic Insert,
Enrolling by invitation
- Vitreoretinal Surgery
- +3 more
- Dexamethasone Ophthalmic Insert
- Prednisolone Acetate 1% Oph Susp
-
Cleveland, OhioCole Eye Institute, Cleveland Clinic
Feb 24, 2022
Cataract Trial (Dexamethasone 0.4 MG [Dextenza])
Not yet recruiting
- Cataract
- Dexamethasone 0.4 MG [Dextenza]
- (no location specified)
Nov 22, 2021
Dry Eye Syndromes, Eye Diseases Trial in Memphis (OTX-DED, Controlled Insertion, Collagen Punctal Plug)
Not yet recruiting
- Dry Eye Syndromes
- Eye Diseases
- OTX-DED
- +2 more
-
Memphis, TennesseeOcular Therapeutix
Apr 12, 2023
Cataract Trial (Dexamethasone 0.4 MG [Dextenza])
Not yet recruiting
- Cataract
- Dexamethasone 0.4 MG [Dextenza]
- (no location specified)
Oct 27, 2021
Pterygium of Both Eyes Trial in Brandon (Intracanalicular Dexamethasone, (0.4 mg) Insert, Prednisolone Acetate)
Active, not recruiting
- Pterygium of Both Eyes
- Intracanalicular Dexamethasone, (0.4 mg) Insert
- Prednisolone Acetate
-
Brandon, FloridaBrandon Eye Associates
Jul 19, 2022
Cataract Surgery, Glaucoma Surgery Trial (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Ophthalmic Suspension [PRED
Withdrawn
- Cataract Surgery
- Glaucoma Surgery
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate 1% Ophthalmic Suspension [PRED FORTE]
- (no location specified)
Nov 16, 2021
DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract
Completed
- Anterior Chamber Inflammation
- +7 more
- Dextenza 0.4Mg Ophthalmic Insert
-
Los Angeles, CaliforniaAdvanced Vision Care
Jul 14, 2021
Dry Eye Disease, Cataract Surgery, Ocular Surface Disease Trial (Dextenza 0.4Mg Ophthalmic Insert)
Not yet recruiting
- Dry Eye Disease
- +2 more
- Dextenza 0.4Mg Ophthalmic Insert
- (no location specified)
Dec 10, 2020
Glaucoma, Primary Open Angle, Cataract Trial in Torrance (Intracanalicular Dexamethasone, 0.4 mg insert)
Unknown status
- Glaucoma, Primary Open Angle
- Cataract
- Intracanalicular Dexamethasone, 0.4 mg insert
-
Torrance, CaliforniaWolstan and Goldberg Eye Associates
Jul 6, 2020
Corneal Edema, Corneal Defect, Anterior Chamber Inflammation Trial in Los Angeles (Dextenza 0.4Mg Ophthalmic Insert,
Not yet recruiting
- Corneal Edema
- +6 more
- Dextenza 0.4Mg Ophthalmic Insert
- +3 more
-
Los Angeles, CaliforniaAdvanced Vision Care
Dec 5, 2022
Steroid Ophthalmic Insert Trial (Dextenza 0.4Mg Ophthalmic Insert, Topical Fluorometholone)
Not yet recruiting
- Steroid Ophthalmic Insert
- Dextenza 0.4Mg Ophthalmic Insert
- Topical Fluorometholone
- (no location specified)
Oct 17, 2022
Patient Preference Trial in Garden City (Dexamethasone, Standard of care surgery)
Unknown status
- Patient Preference
- Dexamethasone
- Standard of care surgery
-
Garden City, New YorkOphthalmic Consultants of Long Island
Dec 17, 2019
Cataract Trial in Northbrook (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1%)
Enrolling by invitation
- Cataract
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate 1%
-
Northbrook, IllinoisWyse Eyecare
Jan 17, 2023
Ocular Rosacea Trial (Dextenza 0.4Mg Ophthalmic Insert, Fluoromethalone .01%)
Not yet recruiting
- Ocular Rosacea
- Dextenza 0.4Mg Ophthalmic Insert
- Fluoromethalone .01%
- (no location specified)
Apr 8, 2021